-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DKcRGOLciXdro/bk8YVhDRYq1lJoqiiJrJvVK6jsptAKOnyl190iNrlqvDnAnMXG VTwqkzkFHdpB+AOSdfwVOA== 0001179110-11-003652.txt : 20110228 0001179110-11-003652.hdr.sgml : 20110228 20110228193518 ACCESSION NUMBER: 0001179110-11-003652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110224 FILED AS OF DATE: 20110228 DATE AS OF CHANGE: 20110228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winningham Rick E CENTRAL INDEX KEY: 0001302443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 11648435 MAIL ADDRESS: STREET 1: 901 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0303 4 2011-02-24 0 0001080014 THERAVANCE INC THRX 0001302443 Winningham Rick E THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Common Stock 2011-02-24 4 M 0 135950 8.525 A 692223 D Common Stock 2011-02-24 4 S 0 93100 21.45 D 599123 D Common Stock 2011-02-25 4 M 0 135850 8.525 A 734973 D Common Stock 2011-02-25 4 S 0 50200 22.22 D 684773 D Common Stock 2011-02-25 4 S 0 42000 22.74 D 642773 D Common Stock 2011-02-28 4 M 0 101752 8.525 A 744525 D Common Stock 2011-02-28 4 S 0 29800 22.49 D 714725 D Common Stock 2011-02-28 4 S 0 37200 23.49 D 677525 D Stock Option (Right to Buy) 8.525 2011-02-24 4 M 0 135950 0 D 2011-12-08 Common Stock 135950 237602 D Stock Option (Right to Buy) 8.525 2011-02-25 4 M 0 135850 0 D 2011-12-08 Common Stock 135850 101752 D Stock Option (Right to Buy) 8.525 2011-02-28 4 M 0 101752 0 D 2011-12-08 Common Stock 101752 0 D Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c). This transaction was executed in multiple trades at prices from $20.85 to $21.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices from $21.57 to $22.56. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices from $22.57 to $22.85. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices from $22.09 to $22.99. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices from $23.00 to $23.95. The price reported above reflects the weighted average sale price. Immediately exercisable Bradford J Shafer as Attorney-in-Fact 2011-02-28 -----END PRIVACY-ENHANCED MESSAGE-----